SCHEMBL19802009

SCHEMBL19802009

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc(-c5c6ccccc6c(-c6ccc(-c7ccc(-c8c9ccccc9c(-c9ccccc9)c9cc(-c%10ccc(-c%11ccc%12c(c%11)c%11cnccc%11n%12-c%11ccccc%11)cc%10)ccc89)cc7)cc6)c6cc(-c7cccc(-c8ccc9c(c8)c8cnccc8n9-c8ccccc8)c7)ccc56)cc4)cc3)c3cc(-c4ccccc4-c4ccc5c(c4)c4cnccc4n5-c4ccccc4)ccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.36
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX5 P09917 1/20 0.33
PIK3CA P42336 1/20 0.33
DYRK1A Q13627 2/20 0.32
GSK3B P49841 1/20 0.32
KCNH2 Q12809 1/20 0.32
MAPK10 P53779 1/20 0.32
IMPDH2 P12268 1/20 0.32
ALK Q9UM73 1/20 0.32
PDE10A Q9Y233 1/20 0.32
CYP17A1 P05093 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAOA P21397 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17366405 0.96 KDM4E (0.36) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL12169063 0.94 KDM4E (0.37) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL17366384 0.94 KDM4E (0.37) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL12169056 0.93 KDM4E (0.38) KMT2AMEN1HSP90AA1MAPTKDM4E
SCHEMBL17366404 0.93 KDM4E (0.38) KMT2AMEN1HSP90AA1MAPTKDM4E
SCHEMBL17680016 0.93 KDM4E (0.38) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL12168993 0.92 KDM4E (0.39) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL12098192 0.92 ATM (0.39) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL21249193 0.91 KDM4E (0.36) TNFKMT2AMEN1HSP90AA1MAPT
SCHEMBL17366401 0.91 KDM4E (0.36) TNFKMT2AMEN1HSP90AA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10505119-B2 Organic electroluminescence device HODOGAYA CHEMICAL CO., LTD. (JP) 2019-12-10 US disclosed
US-20180026198-A1 ORGANIC ELECTROLUMINESCENCE DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10505119-B2 Organic electroluminescence device AHR, ARNT, NAT1 TNF 4802/4885KMT2A 1347/4885MEN1 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.